Genzyme Corporation: PharmaVitae Profile in China
Original Source: Genzyme Corporation Market
Buy Now: Research
This analysis examines the historical and forecast performance for Genzyme in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs
An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
Benchmark Genzyme’s performance against key rivals in the prescription pharmaceutical sector
See how the company’s core products of Cerezyme, Fabrazyme and Myozyme/Lumizyme will continue to act as the primary sales growth drivers
Assess the impact of the recent contamination of the Allston manufacturing facility on the company’s performance through 2009
Table Of Contents
ABOUT DATAMONITOR HEALTHCARE 2
Chapter 1 About this profile 3
Chapter 1 About this profile 3
Chapter 2 Executive summary 5
Chapter 3 Quarterly news update 24
Chapter 4 Company introduction 30
Chapter 5 Company sales 38
Chapter 7 Key products and competitors 80
Chapter 8 Appendix 109
R&D pipeline 109
References 110
Datamonitor reports 110
Abbreviations 110
About Datamonitor 112
About Datamonitor Healthcare 112
Datamonitor consulting 112
Disclaimer 114
Processing your request, Please wait....
